1-6 of 6
Bin Zou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6751: AT2604 is a highly efficacious ADC targeting alkaline phosphatases ALPP and ALPPL2

Bryan K.S. Yeung, Wei Qi Tan, You Xue Wu, Xi Yun Zhang, Yin Wen Cheng, Shao Jun Liu, Chen Zhong, Bin Zou
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6751.
https://doi.org/10.1158/1538-7445.AM2025-6751
Published: 21 April 2025
View articletitled, Abstract 6751: AT2604 is a highly efficacious ADC targeting alkaline phosphatases ALPP and ALPPL2
Journal Articles

Abstract 6741: AT65474, a highly selective anti-CLDN6 ADC with a proprietary payload

Chen Zhong, Yin Wen Cheng, You Xue Wu, Xi Yun Zhang, Rui Yang Zhao, Qian Wang, Ping Du, Shao Jun Liu, Bin Zou
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 6741.
https://doi.org/10.1158/1538-7445.AM2025-6741
Published: 21 April 2025
View articletitled, Abstract 6741: AT65474, a highly selective anti-CLDN6 ADC with a proprietary payload
Journal Articles

Abstract 3138: Discovery of AT65474, a highly selective anti-CLDN6  ADC with a proprietary payload

Chen Zhong, You Xue Wu, Xi Yun Zhang, Yin Wen Cheng, Qian Wang, Ping Du, Shao Jun Liu, Bin Zou
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3138.
https://doi.org/10.1158/1538-7445.AM2024-3138
Published: 22 March 2024
View articletitled, Abstract 3138: Discovery of AT65474, a highly selective anti-CLDN6  ADC with a proprietary payload
Journal Articles

Abstract 3137: Development of AT2604, a highly efficacious  ADC targeting alkaline phosphatases ALPP  and ALPPL2​

Bryan K. Yeung, Xiao Hui Koh, Wei Li Ling, Weiqi Tan, You Xue Wu, Xi Yun Zhang, Hong Yee Tan, Shao Jun Liu, Chen Zhong, Bin Zou
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3137.
https://doi.org/10.1158/1538-7445.AM2024-3137
Published: 22 March 2024
View articletitled, Abstract 3137: Development of AT2604, a highly efficacious  ADC targeting alkaline phosphatases ALPP  and ALPPL2​
Journal Articles

Abstract 1858: Discovery of AT86474, a highly efficacious anti-ROR1 ADC utilizing a proprietary payload

Ban Xiong Tan, Xi Yun Zhang, You Xue Wu, Yin Wen Cheng, Shao Jun Liu, Ping Du, Chen Zhong, Bin Zou
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1858.
https://doi.org/10.1158/1538-7445.AM2024-1858
Published: 22 March 2024
View articletitled, Abstract 1858: Discovery of AT86474, a highly efficacious anti-ROR1 ADC utilizing a proprietary payload
Journal Articles

An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response

Hongping Dong, Shaojun Liu, Xuejie Zhang, Sheng Chen, Lijing Kang, Yanni Chen, Shichao Ma, Xianlei Fu, Yanchao Liu, Hailong Zhang, Bin Zou
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5587–5596.
https://doi.org/10.1158/0008-5472.CAN-19-0428
Published: 01 November 2019
View articletitled, An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response
Open the PDF for An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response in another window
Includes: Supplementary data